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A B S T R A C T
Production of 3-dimensional neural progenitor cultures from human pluripotent stem cells offers the potential to
generate large numbers of cells. We utilised our nanobridge system to generate 3D hPSC aggregates for differ-
entiation towards the neural lineage, and investigate the ability to passage aggregates while maintaining cells at
a stem/progenitor stage. Over 38 days, aggregate cultures exhibited upregulation and maintenance of neural-
associated markers and demonstrated up to 10 fold increase in cell number. Aggregates undergoing neural
induction in the presence or absence of nanobridges demonstrated no differences in marker expression, pro-
liferation or viability. However, aggregates formed without nanobridges were statistically significantly fewer
and smaller by passage 3. Organoids, cultured from aggregates, and treated with retinoic acid or rock inhibitor
demonstrated terminal differentiation as assessed by immunohistochemistry. These data demonstrate that na-
nobridge 3D hPSC can differentiate to neural stem/progenitor cells, and be maintained at this stage through
serial passaging and expansion.
1. Introduction
Neurodegenerative diseases (e.g. neurological disorders and de-
mentias) result in progressive loss of structure and neurological func-
tion, including the death of neurons. Dementia is expected to pose a
significant health and socio-economic burden, estimated to affect 131.5
million people in 2050 and costing a trillion US dollars in 2018 alone
(Martin et al., 2015). Current treatment of degenerative brain diseases
are based on imprecise symptomatic treatment (Chen and Pan, 2014).
This limitation has driven an intensive search for new therapeutic in-
terventions, including the use of human pluripotent stem cells (hPSC).
These cells can be used as a platform for drug development or as a
source for cellular therapies, with the potential to transform approaches
to injury treatment, disease management and drug discovery. Expan-
sion of hPSC to the cell numbers required for these applications remains
a critical challenge. Of equal importance is the differentiation of hPSC
to progenitor cells of particular lineages and their subsequent expansion
to large cell numbers required for clinical and pharmacological use.
While two dimensional (2D) monolayer cell cultures continue to be
utilised in the majority of stem cell expansion systems, three dimen-
sional (3D) cultures of hPSC have been demonstrated to far outperform
2D cultures for scale-up (Chen et al., 2012; Chen et al., 2014). Culturing
cells in 3D provides a more physiologically relevant environmental
niche and can offer a more realistic model of the developmental pro-
cesses in differentiation and the cell-cell interactions involved
(Akkerman and Defize, 2017).
Differentiation of hESC towards neuronal lineages has been ex-
tensively studied, with current methods increasingly using small mo-
lecule inhibitors to tightly regulate initial stages of differentiation and
to aid in supplying a more precise temporal control for downregulation
of pluripotency markers (Chambers et al., 2012; Wattanapanitch et al.,
2014). Many monolayer differentiation and expansion methods for
neural progenitors include labour intensive and time-consuming
manual dissection. This limits the available cell numbers, and
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additionally, as 2D cultures cannot emulate the natural 3D environment
they may result in misleading outcomes when utilizing results as a
predictive response for in vivo applications (Edmondson et al., 2014).
Advances in CNS organoid culture have allowed the observation of
specific morphogenetic events in brain development, and have pro-
vided insights into cell interactions that are beneficial for modelling
and histotypic differentiation (Jo et al., 2016; Kelava and Lancaster,
2016; Lancaster et al., 2013; Werner et al., 2016). Recent data has
demonstrated that implantation of brain organoids in mouse brain de-
monstrate both functionality and vascularisation (Mansour et al.,
2018). However, many organoid culture systems lack reproducibility,
and present challenges when the structures must be dissociated for
single cell analysis (Huch et al., 2017).
The generation of neural stem or progenitor cells (NPC) and their
subsequent differentiation to terminal cell types using 3D cultures and
scaffolds have been reported. These include methods utilizing hydrogels
(Li et al., 2012; Adil et al., 2017; Rodrigues et al., 2017), alginate
(Bozza et al., 2014) and fibrin matrix (Sadri et al., 2014); or passive
aggregation in the absence of supporting materials (Chandrasekaran
et al., 2017). Li et al. demonstrated that the larger pore size metha-
crylamide chitosan hydrogel photocrosslinked to D-mannitol could
support differentiation of NPC to neurons, oligodendrocytes and as-
trocytes; however, these large pore sizes led to decreased cell numbers
(Li et al., 2012). Adil et al. and Rodrigues et al. both utilised com-
mercial hydrogels (Mebiol gels, Adil et al., 2017; PNIPAAm-PEG,
Rodrigues et al., 2017) to establish 3D hESC aggregates, subsequently
differentiating cells towards dopaminergic neurons and oligoden-
drocyte precursors respectively. Encapsulation of mouse ESC in alginate
beads using hyaluronic acid (HA) or fibronectin (FN) enhanced the
differentiation ability of the cells (Bozza et al., 2014). HA combined
with alginate and alginate alone increased neuronal differentiation of
the cells as compared to FN treated alginate (Bozza et al., 2014). Sadri
et al. demonstrated a reduction of apoptosis in 3D as opposed to 2D
cultures (Sadri et al., 2014). When directly comparing 2D versus 3D
cultures, Chandrasekaran et al. demonstrated increased neuron num-
bers, process length and glial progenitor formation in 3D cultures of
differentiating hPSC (Chandrasekaran et al., 2017). Although this body
of work demonstrated the advantages of 3D systems to differentiate
mouse and human PSC towards neuronal cells, aggregate size was not
controlled, a factor that can result in necrotic cores becoming estab-
lished in nutrient deficient areas. Importantly the above studies were
designed to investigate terminal differentiation, did not investigate if
neural progenitor cells could be maintained during serial passaging,
and routine passaging was performed using enzymatic or non-enzy-
matic methods.
The work presented here addresses the critical need to develop a 3D
expansion method that facilitates aggregation and offers the capacity to
control aggregate size by passaging during differentiation. Using our
method, aggregates can then be easily grown in a cyclic manner for
rapid expansion to obtain large cell yields, while maintaining the cells
in the state of choice. This method overcomes reported issues in low
efficiency in formation of aggregates and control over aggregate size
(Chandrasekaran et al., 2017).
Here, we demonstrate a 3D cell culture method that allows hPSC to
be differentiated to, and expanded as, NPC. Previous publications have
demonstrated the presence of necrotic cores in cancer spheroids of ≈
500 μm (Daster et al., 2017; Hirschhaeuser et al., 2010), thus, we in-
vestigated if controlling aggregate size prevented the formation of a
necrotic core and, additionally, if the aggregates could differentiate
towards a terminal neuronal phenotype. The 3D culture system con-
sisted of a thermoresponsive nanobridge system (NB) allowing a tem-
perature shift to be utilised in conjunction with a low mechanical shear
to dissociate the aggregates to smaller clumps (i.e. without the addition
of enzymatic treatment) (Chen et al., 2017; Chen et al., 2014). Neural
differentiation was initiated when aggregates reached an average dia-
meter between 200 and 300 μm. Passaging was performed throughout
the culture period maintaining an average diameter of between 300 and
450 μm. We investigated if using this method could maintain the ag-
gregates at the neural stem/progenitor stage and tested the efficacy of
the differentiation against conventional monolayer cultures of hPSC
undergoing neural induction. Our 3D culturing method provides a more
robust and less labour intensive approach for generating and main-
taining differentiated hPSC as neural stem/progenitor cells, and has the
potential for large-scale production.
2. Materials and methods
2.1. Cell culture and aggregate formation
hESC (WA09 (WiCell Research Institute Inc), ESI-hES3 (Embryonic
Stem Cell International Pte Ltd., Singapore), and MEL1 (University of
Queensland)) were routinely cultured as adherent cells in mTeSR1
media (STEMCELL Technologies) on Matrigel™ coated wells (MG™;
Corning). To generate 3D aggregates for culture in a 96 well platform,
2D cells were washed with phosphate buffered saline without Ca2+ and
Mg2+ (PBS2-) and dissociated to single cells using TrypLE (Thermo
Fisher Scientific). Cell counts were performed and 70,000 cells/ml were
mixed with the NB components (50 μg/ml PNIPAM-b-rFN, 50 ng/ml of
the pWorms) as previously described (Chen et al., 2014). Detailed
protocols to determine the polymer concentrations can be found in
Chen et al. (Chen et al., 2017). The combination of both polymer
components is referred to as NB. 50 μl aliquots of cells at a concentra-
tion of 70,000 cells/ml, with or without NB, were aliquoted into 60
wells of a 96 well U shaped low attachment culture dish (Corning) and
centrifuged at 37 °C for 5 mins at 480 G. Plates were incubated at 5%
CO2, 37 °C overnight and examined the following day for aggregate
formation.
For 6 well cultures, hESC were passaged using Gentle Cell
Dissociation reagent (STEMCELL Technologies) to produce small
clumps of cells. Cells were mixed with the above-mentioned NB con-
centrations, and incubated overnight at 5% CO2, 37 °C in 6 well low
cluster plates (Corning). Cell counts were performed on the day dif-
ferentiation was initiated. A maximum of 2× sub confluent 2D wells
from a 6 well plate were used to generate 1 well of a 6 well 3D culture.
2.2. Neural induction
Neural induction for both 96 and 6 well cultures was started (day 0)
when the average aggregate width was between 200 and 300 μm.
Differentiation was based on a modification of the method published by
Chambers et al. (Chambers et al., 2009) where 100 nM LDN 193189
(Stemgent Inc.) replaced Noggin. Briefly, aggregates were cultured in
5 μM SB431542 (Miltenyi Biotech) and 100 nM LDN 193189 (Stemgent
Inc.) in mTeSR1 media for 5 days. At d5 the medium was changed to
neural basal media (with 1× B27, 1× N2, 1× ITS-A, 1× Glutamax
(NBM; all Invitrogen)) and supplemented with 20 ng/ml EGF (Pepro-
Tech) and 20 ng/ml FGF2 (Invitrogen) for the next 5 days of culture.
This protocol was utilised as the base method for all routine cultures
performed in NBM, FGF2 and EGF were withdrawn from d10 onwards.
Passaging was performed at d10 and, thereafter, on a weekly basis. Six
well cultures were grown under static conditions. To decrease the
possibility of aggregates clumping under static conditions and to
maintain the maximum average aggregate width at passage of ≈
450 μm, cultures were passaged at d5 and d10 during induction, and
thereafter on a weekly basis.
To examine the effect of neural growth factors FGF2 and EGF on the
3D culture system single aggregates, cultured in a 96 well format in
NBM, were supplemented with EGF alone, FGF2 alone, EGF/FGF2
added weekly, daily or a sustainable form of FGF2 (with EGF) added
twice weekly (Speed BioSystems, Maryland, USA).
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2.3. Terminal differentiation
To establish if 3D NB aggregates could yield terminally differ-
entiated cells, WA09 96 well cultures underwent dual SMAD inhibition
and neural induction with EGF and FGF2 before supplementation with
either Rock inhibitor Y27632 (25 μM, RI, Miltenyi Biotech) or retinoic
acid (50 μM, RA, Sigma-Aldrich) for a maximum of 12weeks of culture.
Samples were taken at weeks 4 (d38), 8 (d66) and 12 (d94) for RT-PCR
and at week 8 and 12 aggregates were manually dissociated and al-
lowed to outgrow for 5 days in NBM alone before staining.
2.4. Proliferation, viability and aggregate diameter
To examine proliferation and aggregate growth, cell counts were
performed at d5, d10 and prior to passaging on a weekly basis (p1d7
etc). Proliferation was calculated using seeding density of aggregates on
the day of induction (d0) as baseline and for generating fold expansion
for each data point (over d0 data). Viability was assessed using Trypan
Blue. To calculate diameter, aggregates were imaged on a Nikon Eclipse
Ti-U inverted microscope using automated acquisition for imaging and
to stitch images together (NIS-Elements, Nikon). Individual images
were outlined in Photoshop using the elliptical marquee or lasso tools
and aggregate width was calculated using the Photoshop analysis tool.
For the purposes of this manuscript ‘diameter’ is used as the measure.
Measurement scale was set using the NIS Element generated scale bar
and the diameter data generated in μm. Minimally, 3 independent ex-
periments were performed with 60 aggregates analysed per experiment
at each time point.
2.5. Gene expression
Samples for RT-PCR were taken at d0, d5, d10, and thereafter on a
weekly basis (passage 1 (p1), p2, p3, p4). As an indicator of differ-
entiation efficiency under 3D conditions WA09 were cultured as 2D
using the above base method (without passaging) and samples taken for
RT-PCR at the same time intervals. A minimum of 3 experiments were
performed for each cell line as 96 or 6 well or 2D cultures.
RNA was extracted from aggregates using an RNeasy purification
mini kit (Qiagen) including treatment using an RNase-free DNase set
(Qiagen) according to manufacturer's instructions. cDNA was generated
using a RevertAid First Strand cDNA synthesis kit (Thermo Fisher
Scientific) according to manufacturer's instruction. RT-PCR was per-
formed on 10 μg of cDNA for each reaction with 2× Fast SYBR green
master mix (Applied Biosystems) using a 7500 fast real-time PCR ma-
chine (Applied Biosystems). Cycle threshold (CT) values for each primer
set were normalised to a geometric mean of four housekeeping genes
(βActin, TBP, B2M, HPRT1) and analysis performed using the com-
parative ΔΔCT method. Data is plotted as expression relative to the
geometric mean of all housekeeping genes. Primer sets were purchased
from either GeneWorks, (Thebarton, South Australia) or Integrated
DNA Technologies (Singapore) and included POU5F1 (Octamer-binding
transcription factor 4), NANOG, DNMTB3 (DNA methyltransferase 3
beta), PAX6 (paired box protein 6), SOX1 (SRY-Box 1), NCAM (neural
cell adhesion molecule), HOXA3 (homeobox protein HOX-A3), MAP2
(microtubule-associated protein 2) and DCX (Doublecortin). In addi-
tion, aggregates cultured in media supplemented with either RI or RA
were examined for expression of GFAP (Glial fibrillary acidic protein),
S100B (S100 calcium-binding protein B), FOXD3 (Forkhead box protein
D3), NEUROG1 (Neurogenin-1), HOXA3 and EN1 (Engrailed-1).
2.6. Immunostaining
To establish if a necrotic core formed during culture, intact ag-
gregates, at each passage, were stained for 1–2 h at 37 °C, 5% CO2 in
10 μg/ml Hoechst 33342 or CyQUANT (diluted 1:10 in culture media
instead of 1:2, otherwise prepared according to manufacturer's
instructions) and 10 μM DRAQ7 before imaging using the IN Cell
Analyzer 2200 (GE Healthcare). Eleven to 15 slices, with a 5 μm dis-
tance between slices, were imaged and deconvoluted. Images were
loaded in ImageJ, stacked and processed using the Z project to create
one image from the slices, in addition, a surface plot of live and dead
cells was created using ImageJ-Fiji (Schneider et al., 2012).
To ascertain if downregulation of POU5F1 protein could be ob-
served in intact aggregates and if differentiation occurred throughout
the aggregate or at specific locations (central or peripheral) daily
samples were taken over the initial 5 day period (d0-d4 of SMAD in-
hibition). Samples were washed in PBS2-, fixed and washed 3× in
PBS2- (30 mins for fixation and all washes). To enhance the clarity of
the 3D aggregate, ScaleA2 (Hama et al., 2011), a solution which allows
optical clearing, was utilised prior to staining. Post fixation, aggregates
were incubated overnight in a 20% sucrose solution and then trans-
ferred to Scale A2 for two further days. Both incubations were per-
formed at room temperature. To provide comparable data for 3D
measurement of protein expression, aggregates between d0 and d4
were dissociated by manual pipetting, plated onto pre-coated MG™
Nunc F (flat) 96 well plates (Thermo-Fisher Scientific), and incubated
overnight at 37 °C, 5% CO2. The following day wells were washed in
PBS2-, fixed in 10% formalin, and washed a further three times in PBS2-
(minimum of 5 mins/wash).
3D aggregates were incubated in blocking buffer (PBS2-, 0.1%
TritonX-100, 4% normal goat serum) at room temperature (RT) for 4 h
before addition of primary antibody (mouse) POU5F1, recognising the
A isoform related to pluripotency (Wang and Dai, 2010) (2 μg/ml; Santa
Cruz (SC); C-10; sc-5279). Aggregates with antibody were incubated
overnight, in staining buffer (PBS2-, 0.1% TritonX-100, 1% bovine
serum albumin) at 4 °C. The aggregates were washed 3× in PBS2- be-
fore incubation with a goat anti-mouse 488 Alexa Fluor secondary
(2 μg/ml, Thermo Fisher Scientific) for 4 h at RT; again washed 3× in
PBS2- and placed in 10 μg/ml Hoechst 33342. Aggregates were then
transferred, in Hoechst 33342, to a 384 well plate at 1 aggregate/well
and 5 aggregates/time-point, for 4 biological replicates (n=4).
For dissociated and replated aggregates d0–4 of 96 well cultures
(WA09 only), d0, d5, d10, p1, p2, p3 and p4 from 6 well cultures
(WA09, ESI-hES3, MEL1)) and terminal differentiated aggregates
(WA09 only) a similar staining protocol to that above was utilised,
however there was no pre-treatment with sucrose and ScaleA2. Primary
antibodies (mouse POU5F1 (SC), mouse PAX6 (3.5 μg/ml,
Developmental Studies Hybridoma Bank), rabbit SOX1 (1:400 dilution,
#4194, Cell Signalling), mouse MAP2 (2.5 μg/ml, AP20, MAB3418,
Millipore)) and mouse Tubulin, Beta III (1:400 dilution, EMD Millipore,
clone TU-20) were incubated overnight at 4 °C. Incubation in blocking
buffer and Alexa Fluor secondaries (goat anti-mouse or goat anti-rabbit)
were carried out for 2 h at RT. DRAQ5 (10 μM, AbCam) or Hoechst
33342 (10 μg/ml) were used as nuclear stains for 30 mins at RT and all
washes were performed for 5 mins in PBS2-.
Organoids cultured for terminal differentiation were fixed, histolo-
gically processed, and embedded in paraffin wax before sectioning at
5 μm. Sections were stained, using an antigen retrieval method, with
PAX6 (rabbit, 1:50 dilution, AbCam), MAP2 (rabbit, 1:3000 dilution,
AbCam), Tubulin, Beta III (mouse, 1:100 dilution, Santa Cruz
Biotechnology), Nestin (rabbit, 1:400 dilution, Santa Cruz
Biotechnology), GFAP (mouse,1:50 dilution, Cell Signalling) and anti-
Oligodendrocyte protein (rabbit ab53041,1:500 dilution, AbCam).
Alexa Fluor secondaries (goat anti-mouse or goat anti-rabbit) were
utilised at 1:500 and sections were counterstained with Hoechst.
Fluorescent images of stained organoids were scanned using a Nikon
Eclipse Ni microscope at 20× magnification.
2.7. Imaging and analysis of fluorescent staining
Imaging was performed on an InCellAnalyzer 2200 and analysis
carried out using IN Cell Investigator software (both GE Healthcare). 3D
L. Harkness, et al. Stem Cell Research 38 (2019) 101441
3
and 2D aggregate imaging was performed at 20× magnification. For
3D antibody stained aggregates an average number of 11–15/aggregate
z-slices were acquired at a distance of 5 μm between slices; 3D decon-
volution was performed automatically during and following acquisition
of images. Replated aggregate imaging was performed across 9 fields
centrally placed with fixed spacing per field. All images were analysed
using the Multi Target Analysis module and a threshold filter selected
for each antibody to provide data for the number of positive and ne-
gative cells. Unstained or secondary only stained wells served as a
baseline for detecting positively stained cells.
2.8. Thermoresponsive nanobridges
We have previously reported the generation of 3D aggregates from
2D hESC cultures utilizing a thermoresponsive nanobridge system
consisting of (i) a block copolymer of a thermoresponsive poly(N-iso-
propylacrylamide) (PNIPAM) polymer conjugated to a fibronectin (FN)
fragment (PNIPAM-b-FN) and (ii) thermoresponsive polymer nano-
worms (pWorms) with a PNIPAM corona (Chen et al., 2017; Chen et al.,
2014). A reduction of temperature to 32 °C, which is below the lower
critical solution temperature (LCST) of the PNIPAM chains, causes the
PNIPAM to become water-soluble, allowing cell-cell binding to weaken.
Cell aggregates can then be broken into small clumps by exerting a low
shear force. This allows passage in a suspension culture system without
recourse to enzymatic or non-enzymatic dissociation solutions.
2.9. Statistical analysis
Statistical tests were performed on staining data following IN Cell
Investigator analysis with cell counts, aggregate width, viability and
transcript expression parameters used to establish levels of significance.
Data sets were loaded in GraphPad Prism and multiple comparisons
performed using a one-way ANOVA with a Tukey test post ANOVA, and
multiple t-tests using the Holm-Šídák method to correct for multiple
comparisons. Reported levels of significance were * p<0.05, **
p<0.01, *** p<0.005 and **** p<0.001.
3. Results
Experiments were established to investigate (i) if consistently sized
aggregates could be generated at a high formation rate using the NB;
(ii) if the NB components influenced the differentiation of hESC ag-
gregates; (iii) if neural induction in 3D-hESC NB aggregates cultured on
either a 96 or 6 well platform demonstrated equivalent differentiation
capacity to 2D monolayer cultures; (iv) if culturing cells in 3D induced
the formation of a necrotic core; (v) if the 3D-hESC NB neural induced
aggregates could become terminally differentiated. A diagram depicting
the method for formation, culture and disaggregation can be found in
Fig. 1A.
3.1. Comparison of 96 well cultures with and without nanobridges in hESC
undergoing neural induction
Cultures in 96 well plates were established to determine if 3D ag-
gregates could be differentiated to neural progenitors and if the NB
components effected neuronal differentiation.Cultures of WA09 were
harvested and resuspended as a single cellsuspension, mixed with or
without the NB components, aliquoted in a 96 well plate, centrifuged
and incubated. The aggregate formation rate was high with> 98%
formation in aggregates with and without the NB components.
Aggregates were cultured in the absence or presence of NB in mTeSR1
until anaverage aggregate diameter of ≈ 300 ± 5.9 μm was achieved.
Neural induction was then initiated (d0) and aggregate diameter
monitored and analysed using a one-way ANOVA. No statistically sig-
nificant differences, with or without NB components respectively, were
determined in percentage cell viability (90.6 ± 4.3 vs 88 ± 4.4;
mean ± SD) or proliferation (7.6 ± 1.31 vs 7.6 ± 0.90; mean ± SD)
(Supplementary Fig. S1Ai). Aggregate diameter was statistically sig-
nificantly smaller in cells cultured in the absence of NB components at
d5 and p3 (p<0.001); no significant differences were found at other
time points (Supplementary Fig. S1Ai). Supplementary Fig. S1Aii shows
images of NB generated aggregates at days 0, 5, 10, passages 1–3.
ANOVA analysis of proliferation data over time, with or without NB,
demonstrated significantly increased proliferation rate for both condi-
tions between d0 or d5 and d10, p1, p2 and p3 (p<0.005). Analysis
between d10 and further time points demonstrated that the prolifera-
tion rate did not significantly increase (Supplementary Fig S1Ai).
Aggregate diameter, analysed between sample time points, statistically
significantly increased between d0 and d5, and d5 and d10 (p<0.001),
and statistically significantly decreased between p1 and p2, and p2 and
p3 (p<0.001) irrespective of addition of NB. No significant difference
in aggregate diameter could be found between d10 and p1. A summary
of the statistics are in Supplementary Table S1.
Experiments were terminated at passage 3 day 7 (p3d7) following
decrease of proliferation and concurrent decreases in aggregate dia-
meter irrespective of the addition of NB. No differences were found
between cultures with or without NB when gene expression was ex-
amined (POU5F1, NANOG, DNMT3B, PAX6, SOX1, and NCAM)
(Supplementary Fig. S2A). Staining at p3 demonstrated a few PAX6
positive cells in aggregates formed without NB and limited numbers of
MAP2 positive neurites in aggregates created with and without NB
suggesting that majority of cells had exited the stem cell stages
(Supplementary Fig. S2B).
It became increasingly difficult to manually disaggregate cells cul-
tured without NB components as passage number increased suggesting
that, as previously reported (Chen et al., 2017), the polymer played a
role in the ability to dissociate aggregates. The percentage of aggregates
that reformed at p3d1 was significantly less in cultures without NB
(p3d1 with NB: 88.3% ± 12.6 cf. without NB: 54.6% ± 20.2%;
p<0.05) suggesting a need for the NB in re-aggregation. Additionally,
the diameter of aggregates reformed without NB were significantly
smaller at p3d7 (p<0.001) than those reformed with NB. Significant
differences were not found at any other time point for aggregate for-
mation. Representative images detailing differences between NB and
cultures without polymer at p3d7 can be found in Supplementary Fig.
S1B.
3.2. Proliferation, aggregate diameter and viability in static 6 well cultures
of hESC undergoing neuronal differentiation
To ascertain if the 96 well platform was scalable WA09, ESI-HES3
and MEL1 were established as multi aggregate cultures in a static 6 well
format. Following passaging with Gentle Cell Dissociation reagent small
clumps of hESC were mixed with NB components and cultured in low
cluster 6 well plates. From data acquired in the 96 well plate format, we
determined that (1) aggregates differentiated into neural stem/pro-
genitor cells; (2) there were limited differences in proliferation, tran-
script expression or aggregate diameter between cultures with and
without NB components (Supplementary Figs. S1 and S2). This estab-
lished thatthe NB components had no influence on the differentiation
capacity of 3D cultured hESC. Thus,scale up to 6 well cultures was
performed for NB cultures alone.
WA09 cultures using thestatic 6 well culture platform (Fig. 1B, n =
4) continued proliferation until the termination of the experiment
(p4d7) as compared to the 96 well format. Proliferation (7.5 ± 2.2 fold
expansion at p4d7; mean ± SD) increased across the experimental
periodwith statistical significance demonstrated between d0 and p1
(p<0.05), d0 and p2 (p<0.005); d0 and p3 and d0 and p4
(p<0.001). No significant difference was determined in percentage
cell viability across the culture period (93.7 ± 1.6; mean ± SD). Ag-
gregate diameter was regained after each passage and only decreased
significantly at the end of the culture period (between d5 and p3d7
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p<0.005; and d5 and p4d7 p<0.001). Images from aggregates un-
dergoing initial induction and following final disaggregation (p4d1)
and final growth (p4d7) can be seen in Fig. 1B.
Two additional hESC lines (ESI-hES3 and MEL1; Supplementary Fig.
S3) were differentiated as static 6 well cultures. Both cell lines showed
similar patterns to the WA09 in viability, proliferation and recovery of
aggregate diameter following passaging. Statistics for proliferation and
diameter for the single and multi-aggregate cultures are reported in
Supplementary Table S1.
3.3. Gene expression analysis of monolayer and 3D (96 well and 6 well)
neuronal cultures
Gene expression analysis (Fig. 2 and Supplementary Figs. S2, S4 and
S5) demonstrated significant downregulation (p<0.01; d0 vs d10) of
pluripotency markers POU5F1, NANOG, and DNMT3B in all three cell
lines and across different culture conditions (2D adherent monolayer,
3D in 96 well and 3D static 6 well). No significant differences could be
detected between NB and no polymer cultures in transcript levels of
PAX6, SOX1 or NCAM (Supplementary Fig. S2). In WA09, 2D mono-
layer cultures demonstrated slower downregulation at d5 of both
NANOG and DNMT3B as compared to both 96 and 6 well 3D cultures.
Increased transcript levels for genes associated with early neural dif-
ferentiation, (PAX6, SOX1 and NCAM) were observed in cells cultured
as 3D aggregates as compared to 2D monolayer cultures however these
were not significant for SOX1 (Fig. 2, Supplementary Table S3). While
ESI-hES3 and WA09 demonstrated similar patterns of gene expression
for all genes analysed (PAX6, SOX1, NCAM, HOXA3, DCX, MAP2),
MEL1 demonstrated a different profile for PAX6 where significant
downregulation was observed at p2 (p<0.005), however protein ex-
pression of PAX6 could still be observed at p4 (Supplementary Fig. S5).
DCX has been reported to identify postmitotic neurons with inhibited
proliferation and migratory potential (Filipovic et al., 2012). Rises in
transcript levels of DCX in combination with HOXA3 were observed in
all 6 well static cultures towards the end of the culture period with a
few cells demonstrating MAP2 positive neurite outgrowth. HOXA3 and
Fig. 1. 3D culture of hESC undergoing neuronal induction. A. Diagram depicting the basic method for creation and maintenance of hESC with or without nanobridges
to aggregate and dissociate the hESC. B.6 well culture platform: WA09 were dissociated to small clumps, mixed with the nanobridges, and cultured to form
aggregates overnight; passaging was performed at d5, d10 then weekly (i) graphs depicting cell viability, fold proliferation and aggregate diameter (μm); (ii)
micrographs depicting changes in aggregate width during culture. Scale bar= 500 μm; LCST= lower critical solution temperature; n= 3 independent experiments,
mean ± standard deviation (SD).
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MAP2 are associated with hindbrain development (Philippidou and
Dasen, 2013) and stabilisation of microtubules (Dehmelt and Halpain,
2005) suggesting that, when combined with slowing proliferation and
aggregate width, that a few cells were progressing towards, and past,
the post-mitotic stage.
3.4. Staining and analysis of replated and intact 96 well cultured aggregates
High content imaging and analysis (HCA) allows rapid and auto-
mated image acquisition that can be used to detect changes in cellular
morphology and investigate protein expression in individual cells. We
utilised HCA to investigate the presence/absence of a necrotic core and
to establish how efficiently the POU5F1 protein was down regulated
within NB aggregates during early differentiation.
Imaging of live and dead cells in intact aggregates did not show a
concentration of dead cells in the centre of the aggregate, rather DRAQ7
positive cells were evenly distributed throughout the aggregate sug-
gesting that a necrotic core was not established. Comparison of live/
dead cell counts from InCell analysis equated with manual cell counts
(Supplementary Fig. S6C). To provide an overall impression of the lo-
cation of the dead cells, images at p3 were loaded in ImageJ, stacked
and processed using the Z project to create one image from all slices
(Supplementary Fig. S6A) (Schneider et al., 2012). This demonstrated
an even distribution of dead cells throughout the aggregate. In addition,
a 3D surface plot of CyQUANT (black) and DRAQ7 (white) was created
in ImageJ-Fiji through 50% of an aggregate to further verify the even
distribution of dead cells within aggregates (Supplementary Fig. S6B).
Intact and replated (overnight) WA09 96 well aggregates were ex-
amined for POU5F1 protein expression and location between d0 and d4
of differentiation. Analysis was performed on multiple slices (11–15/
aggregate) taken through intact aggregates (5 aggregates per condition,
n=4 independent experiments) and on images taken from 9 fields/well
of replated 3D aggregates (minimum of 3 wells/experiment, n=4 in-
dependent experiments). As demonstrated in Supplementary Fig. S7,
similar patterns for down-regulation of POU5F1 were identified at each
time-point between aggregates analysed intact and those examined
following replating. Induction of differentiation, as measured by
POU5F1 staining, occurred uniformly throughout the aggregates.
Fig. 2. Gene expression of monolayer and 3D hESC cultures undergoing neuronal differentiation. A. down regulation of pluripotency markers POU5F1, NANOG and
DNMT3B in WA09. B. Regulation of neuronal markers PAX6, SOX1, NCAM, HOXA3, DCX and MAP2 in monolayer (2D) and 3D cultures over a total of 38 days of
differentiation. Gene expression, relative to the geometric mean of the housekeeping gene panel, demonstrate that 3D cultures are more efficacious that 2D for
neuronal differentiation. n=3 independent experiments, mean ± SD.
Fig. 3. Staining and analysis of replated WA09 3D aggregates for POU5F1, Nanog, PAX6, SOX1 and MAP2 at d0, d5, d10, p1, p2, p3 and p4 of neuronal differ-
entiation cultured using the 6 well culture platform. A. Analysis of staining demonstrating the % of positive cells counted in high content screened images. B. Images
demonstrate staining for each antibody (AB) and a merged image of AB with Hoechst for pluripotency markers at d0 and d4 and neural markers from d5 of
differentiation. Scale bar= 100 μm. n=4 independent experiments, data plotted as mean ± SD.
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Fig. 4. Organoid differentiation of 3D
nanobridge hESC cultures in NBM or
supplemented with RI and RA. A.
Relative gene expression of differ-
entiation markers GFAP, S100B,
FOXD3, NEUROG1, HOXA3 and EN1 at
days 31, 38, 66 and 94 of differentia-
tion. Upregulation of GFAP, S100B and
NEUROG1 was observed in RI when
compared to RA treated cultures at
d94; EN1 demonstrated upregulation
in RI treated cultures when compared
to RI treatment at d38, 66 and 94; RA
treated cultures demonstrated upregu-
lation of HOXA3 at all points of dif-
ferentiation when compared to RI
treatment (** p<0.01; **** p<
0.001). No difference was observed in
FOXD3 between treatments, however,
FOXD3 was significantly upregulated
between d31 and days 38 and 66
(p< 0.05) in both RI and RA treated
cultures (multiple t-test; n=4 in-
dependent experiments, mean ± SD).
B. Staining in RA treated cultures at
d66 and d94 demonstrating develop-
ment of neurite outgrowth; scale
bar= 100μm. C. Merged images from
scans of organoid sections from NBM
alone or media supplemented with RA
or RI; scale bar= 500μm. MAP2 and
TUBB3 green; GFAP and O4 pink;
Hoechst blue; n=4 independent ex-
periments. (For interpretation of the
references to colour in this figure le-
gend, the reader is referred to the web
version of this article.)
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3.5. Staining and analysis of replated 6 well cultured aggregates
Aggregates from all three cell lines cultured as static 6 well cultures
were plated and stained for NANOG (d0), POU5F1 (d0 and d5), PAX6
(d5, d10, p1-p4), SOX1 (d10, p1-p4) and MAP2 (p1-p4). Representative
images can be found in Fig. 3(WA09), Supplementary Fig. S4 (ESI-
hES3) and Supplementary Fig. S5 (MEL1). Analysis of WA09 staining
demonstrated significant downregulation of POU5F1 between d0 and
d5 (p<0.001). The percentages of PAX6 and SOX1 positive cells in-
creased between d5 and d10 (p<0.005), and p2 and p3 (p< 0.001),
no significant difference was found at other time points. The percentage
of MAP2 positive cells increased at p3 (Fig. 3A; p<0.001).
No significant downregulation of POU5F1 protein expression in ESI-
hES3 was found between d0 and d5, which correlated with slower
down regulation on the transcript level (Supplementary Fig. S4A).
However, by day 10 transcript expression of pluripotency markers were
found to be statistically significantly downregulated (p< 0.001).
Significant increases of PAX6 and SOX1 positive cells were found by
immunostaining between d10 and p1 (p<0.001; Supplementary Fig.
S4B and C). The percentage of positive cells remained high (> 70%)
until p4 when cells significantly decreased to 62% (PAX6) and 57%
(SOX1; p<0.05). MAP2 demonstrated an increase in the number of
positive cells at p4 (p< 0.05), suggesting that the cells had remained at
a neural stem/progenitor stage.
MEL1 exhibited downregulation of both transcript and protein le-
vels of POU5F1 cells between d0 and d10 (p<0.001) and significant
upregulation of PAX6 and SOX1 between d10 and p1 to> 80% positive
cells (p<0.001; Supplementary Fig. S5A and B). These data demon-
strate that, for all three cell lines, the majority of cells continued to
express neural progenitor markers and thus the stem/progenitor cell
stage was induced and maintained.
3.6. Supplementation of 3D cultures with EGF and FGF2 throughout
differentiation
Previous data has reported that EGF and FGF2 can influence neural
stem and progenitor cell populations (Taupin et al., 2000). To examine
if extended supplementation of neural cultures with FGF2/EGF would
aid in maintaining cells in at earliest neural stem cell stages we estab-
lished 3D cultures to investigate effects of these factors on proliferation,
aggregate diameter and gene expression. Levenstein et al. reported that
during overnight incubation at 37 °C, FGF2 protein levels underwent
significant decay regardless of concentration (Levenstein et al., 2006).
In comparison, controlled release of FGF2 demonstrated maintenance
of pluripotency in hESC (Lotz et al., 2013). The use of sustainable
(thermostable) FGF2 has achieved stable maintenance of FGF2 levels
within culture media thus affecting biological activity (Dvorak et al.,
2018).
Following the initial 10 days of induction, 3D NBM cultures were
supplemented with EGF alone, or FGF2 alone, or EGF and FGF2 added
weekly, or daily, or thermostable FGF2 supplemented twice weekly
(with EGF).
We compared the diameter of EGF/FGF2 supplemented aggregates
using one-way ANOVA. Within individual conditions, aggregate width
decreased in NBM alone from d10 onwards; p1d7 EGF alone; p2d7
FGF2 alone. EGF/FGF2, supplemented on a weekly basis, aggregates
supplemented with sustainable FGF2/EGF twice weekly or on a daily
basis demonstrated significant increases in width until p2d7 the de-
creased in width until experiment termination (p4p7; levels of sig-
nificance were p< 0.001 for all tests; Supplementary Fig. S8A).
Analysis of aggregate diameter between different culture conditions
demonstrated significant differences at most sampling points
(p<0.001); statistics for this analysis are in Supplementary Table S2.
Analysis of proliferation (Supplementary Fig. S8A) demonstrated no
significant differences at d5 or d10 between the different culture con-
ditions. After d10 aggregates cultured in NBM reached a plateau and no
significant proliferation was observed. In comparison, supplementation
with EGF or FGF2 alone demonstrated slower but sustained prolifera-
tion. EGF/FGF2 supplemented weekly, daily or the sustainable FGF2 all
demonstrated increasing proliferation until p2 (p<0.05).
While viability remained high at> 87% across all culture condi-
tions NMB cultures demonstrated decreased viability across all time
points when compared to EGF/FGF2 cultures (p<0.05). Aggregates
cultured in FGF/EGF supplemented NBM all demonstrated suppression
of PAX6, SOX1, HOXA3 and DCX when compared to NBM alone at p3
(Supplementary Fig. S8B, Supplementary Table S4; p<0.005). NCAM
only showed significant differences when EGF/FGF2 were supple-
mented together (p<0.005). MAP2 did not demonstrate any sig-
nificant differences, confirming that addition of EGF/FGF2 maintained
the cells as neural progenitors.
3.7. Aggregate differentiation to neurons
To establish if 3D aggregates were developmentally competent to
differentiate into neurons WA09 aggregates, following dual SMAD in-
hibition and 5 days of neural induction with EGF and FGF2, were cul-
tured as organoids and treated with either RA, RI or in NBM alone
(Fig. 4). Studies have demonstrated that RI supplementation of murine
neural stem cells increased neurite outgrowth and enhanced neuronal
differentiation without affecting cell viability post replating (Jia et al.,
2016). RA has demonstrated a caudalizing effect during neural induc-
tion of stem cells (Allodi and Hedlund, 2014; Liu and Zhang, 2011) and
has exhibited suppression of ventral central nervous tissue (Irioka et al.,
2005). Here, RA treatment, initiated following early differentiation,
was associated with high levels of HOXA3 transcript suggesting in-
duction of a caudal neural fate. Gene expression analysis (Fig. 4A) re-
vealed statistically significant increases in GFAP, S100B, NEUROG1 and
EN1 in RI treated aggregates at d94 as compared to days 31, 38 and 66
or aggregates treated with RA at equivalent time points (** p<0.01;
*** p< 0.005, **** p<0.001). HOXA3 expression was significantly
upregulated in RA cultures when compared with RI at equivalent time
points (** p<0.05 d31 RI vs d31 RA; **** p<0.001 days 38, 66 and
94, RI vs RA). Staining from differentiated aggregates (Fig. 4B) sup-
plemented for 66 days with RA demonstrated PAX6 positive rosettes as
well as neurite outgrowth (MAP2 and TUBB3 staining). At day 94 only a
few cells showed strong expression of PAX6; neurite outgrowth was
identified using MAP2 and TUBB3.
Studies into the neurodegenerative disease aetiology have recently
shown that organoid cultures provide a near-physiological in vitro
model system, allowing investigation of human development, disease
progression and drug discovery (Fatehullah et al., 2016; Jo et al., 2016;
Lancaster et al., 2013; Mason and Price, 2016). Long-term organoid
cultures have the potential to model aspects such as neuronal matura-
tion and survival, and have been demonstrated to faithfully recapitulate
early developmental aspects of the fetal brain (Kelava and Lancaster,
2016; Knowlton et al., 2016). Here, WA09 organoids, cultured for
12weeks (NBM alone, RI treated and RA treated), were fixed and em-
bedded in paraffin before sectioning and staining with MAP2, TUBB3,
GFAP, O4, NES, and PAX6, using Alexa Fluor secondaries and Hoechst
as a DNA counterstain (Fig. 4C, Supplementary Fig. S9). In addition,
sections were stained with H&E and aggregate diameter was measured
and compared across all three conditions. Significant differences were
found in organoid diameter between NBM and the RI/RA treatments
(Supplementary Fig. S9; **** p<0.001). Positive staining for MAP2,
TUBB3, O4, and NES were observed in NBM organoids. RI treated or-
ganoids demonstrated MAP2, TUBB3, and MAP2 staining with some
areas positive for O4. In comparison with NBM and RI treated orga-
noids, limited MAP2 and NES staining was observed in the RA condi-
tion. Neither RA nor RI treatment resulted in GFAP positive cells. PAX6
showed occasional positive cells in all three treatment conditions lo-
calised at the outer edges of the organoids.
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4. Discussion
Successful clinical application of hPSC for the treatment of injury or
disease in the CNS will require robust and reproducible platforms for
generating the requisite numbers of cells. The nanobridge system de-
scribed here is designed to generate aggregates relatively homogeneous
in size and with a high formation rate, which can be readily passaged
without the use of enzymatic or non-enzymatic solutions, and can un-
dergo successful neural induction (Abbasalizadeh et al., 2012; Chen
et al., 2017; Chen et al., 2014).
Within the field of neural tissue engineering, there is increasing
interest in the use of 3D platforms to generate large numbers of neural
progenitors for further differentiation to terminal cell types.
Comparison of the efficacy of 2D vs 3D cultures of hPSC undergoing
neural differentiation has been previously published with, thus far,
widespread agreement that 3D cultures provide better differentiation
and less apoptosis (Chandrasekaran et al., 2017; Ribeiro et al., 2010;
Sadri et al., 2014). However, there has been less emphasis on the ability
to serially propagate and maintain neural progenitors in these 3D sys-
tems. 3D aggregates in many current publications are routinely gener-
ated for terminal differentiation and are not subject to passaging, thus,
as aggregate size increases there is the potential for necrotic cores to
become established. We have validated a system where a high per-
centage of hESC aggregates can be formed, induced to the neural
lineages and disaggregated using a thermoresponsive polymer while
maintaining proliferation and viability. Staining of intact aggregates
verified that live cells were evenly distributed throughout the aggregate
indicating that a necrotic centre was not established possibly due to the
ability to maintain control of aggregate size. However, some 94 day
terminal differentiation cultures, where disaggregation was not per-
formed, demonstrated loss of Hoechst staining in a centralised area (see
Supplementary Fig. S9 RA induction). Aggregates employed for 94 day
differentiation were substantially larger (> 950μm as compared to an
average diameter of 300μm) than those routinely disaggregated. Pre-
vious publications have confirmed the presence of HIF1A necrotic cores
in cancer spheroids of ≈ 500μm and above (Daster et al., 2017;
Hirschhaeuser et al., 2010).
No differences could be determined in transcript or protein ex-
pression in the presence or absence of the nanobridges, confirming that
the NB did not influence the differentiation process. Across the three
cell lines, six well cultures retained a high percentage viability, con-
tinued proliferation and were maintained at average aggregate dia-
meters of between 300 and 450μm. Formation of the aggregates using
the 96 well platform demonstrated high uniformity in diameter.
However, static six well cultures revealed enhanced proliferation, could
maintain aggregate size and progenitor status for an increased number
of passages, as compared to 96 well cultures. While aggregates in the
static 6 well platforms showed higher variability in diameter pre-
liminary experiments comparing hESC cultured using spinner flasks
have shown a greater uniformity in size and shape.
FGF2 has been reported to effect neural differentiation at a number
of different time points. Cohen et al. showed that FGF signalling in
hESC induced early neural specification (Cohen et al., 2010). Israsena
et al., reported that cells cultured in the presence of FGF2 aided in
maintaining the cells at the neural progenitor stage (Israsena et al.,
2004) and Hu et al. described increased numbers of PAX6 cells when
NBM was supplemented with FGF however their data was cell line
dependant (Hu et al., 2010). Increased heterogeneity and rosette mal-
formation has been reported during supplementation of neural stem cell
cultures with FGF2 and EGF (Denham and Dottori, 2009; Elkabetz
et al., 2008). During early rosette formation, FGF2 has been demon-
strated to be involved in rostral-caudal patterning directing neural
differentiation towards forebrain lineages (Denham and Dottori, 2009).
Additionally, FGF signalling in hESC has been shown to induce, but is
not essential, for early neutralization (Cohen et al., 2010). These reports
suggest that FGF2 has biphasic roles during neural induction and that
balancing FGF2 signalling impacts on rosette development and thus
neural fate determination.
Data presented here demonstrated that, similar to Grabiec et al.
where FGF2 repressed the onset of PAX6 in differentiating hESC
(Grabiec et al., 2016; Greber et al., 2011), supplementation of cultures
increased proliferation but transcript levels of PAX6 and SOX1 were
significantly decreased at p3 (p<0.001 and p<0.05 respectively) in
all treatment conditions compared with routine NBM cultures (EGF/
FGF2 withdrawn after 5 days). However, another key marker of neural
differentiation, NCAM, demonstrated transcript levels comparable to
those observed in NBM in EGF alone and FGF2 cultures. This dichotomy
may be explained by the involvement of NCAM in cell-to-cell and cell-
matrix interactions (Eggers et al., 2011).
Terminal differentiation of neural cultures provides an important
proof-of-concept for the aggregates' developmental capacity. We have
demonstrated that growth in the presence of NB does not inhibit dif-
ferentiation to neurons and that when plated the neurons can outgrow
and are positive for TUBB3 and MAP2. Additionally, organoid cultures
treated with RI differentiated towards a neuronal phenotype. In con-
trast, RA treated cultures differentiated to a limited amount of oligo-
dendrocyte and astrocyte cells suggesting that cultures did not differ-
entiate into glial cells. Interestingly, cells grown in NBM alone
contained cells expressing markers of both oligodendrocyte and glial
cells as well as neurones, as evidenced by staining. The 3D cultures
using the NB can provide a robust method for terminal differentiation.
Further investigations are needed to provide functionality of the
terminally differentiated cells and to determine, using in vivo models, if
cells formed in aggregates using NB are competent to integrate into CNS
tissue, vascularise and repair injury.
In conclusion, we have established the capability of the nanobridge
system to generate hESC aggregates that can undergo neuronal differ-
entiation and be expanded and maintained at a stem/progenitor stage.
In addition, aggregates have the capacity to differentiate towards a
more mature phenotype as demonstrated by outgrowth of neurites. The
nanobridge system has no impact on the differentiation process, pro-
liferation or cell viability but aids in maintaining dissociation and re-
aggregation of the cells. The use of a two-component polymer con-
jugated to a small fragment of fibronectin offers the prospect of
adaptability of this system. Small fragments of alternative ECMs, such
as Laminin or Vitronectin, or combinations of ECMs could be utilised
for either alternative lineages or to specify cell type. Our study suggests
that the 3D aggregate cultures are a significantly more effective culture
system in the early stages of differentiation. The 6 well culture platform
is an initial step towards scale-up bioreactor systems which could
generate bulk cultures of hPSC undergoing neural differentiation. This
would allow either for the sampling and distribution of cultures for use
atprogenitor stages or for more terminally differentiated cell types.
Moreover, our system provides a platform for uniform and consistent
generation of large-scale culture of CNS organoid progenitors, which
has several advantages over existing systems for producing organoids.
Our research provides a step towards developing a sustainable and cost
effective platform for furthering the use of stem cells in clinical appli-
cations and drug discovery.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.scr.2019.101441.
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